Nitric oxide and blood pressure in normotensive patients on chronic hemodialysis

Dialysis and Transplantation

Volumn 27, Issue 11, 1998, Pages 714-724

  Viidas, Unni ^a   Ahlmen, Jarl ^a   Hedner, Thomas ^b   Cajdahl, Kenneth ^b   Larsson, Anders ^c   Pettersson, Anders ^b   Strömbom, Ulf ^a  

^a SKARABORG HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARGININE DERIVATIVE; CITRULLINE; CYCLIC GMP; DIMETHYLARGININE; ERYTHROPOIETIN; HEMOGLOBIN; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; UREMIA;

EID: 0031786382     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Viidas U, Noree LO, Ahlmen J, et al. Ambulatory blood pressure and peptide balance in patients on chronic hemodialysis. Scand J Nephrol 1995; 29:259-263.
2. Andersson U, Sylvén C, Lindvall K, et al. Cardiac function and cardiovascular hormone balance during hemodialysis with special reference to atrial natriuretic peptide. Clin Nephrol 1988; 30:303-307.
3. Takahashi K, Mouri T, Tachibana Y, et al. Neuropeptide Y and blood pressure in hemodialysis patients. Endocrinol Jpn 1989; 36:553-558.
4. Portaluppi F, Montanari L, Massari M, et al. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertension 1991; 4:20-26.
5. Murad F Cyclic guanosine monophosphate as a mediator of vasodilatation. J Clin Invest 1986; 78:1-5
6. Alheid U, Frölich JC, Försterman U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res 1987; 47 561-571.
7. Moncada S, Higgs EA. Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21:361-374.
8. Searle NR, Sahab P. Endothelial vasomotor regulation in health and disease. Can J Anaesth 1992; 39:838-857.
9. Dinarello CA. Interleukin-1 and tumor neurosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int 1992; 4(suppl 38): s68-s77.
10. Shaldon S, Deschodt G, Branger, et al. Hemodialysis hypotension. The interleukin hypothesis. Proc Eur Dial Transplant Assoc 1985, 22:229-243.
11. Rees D, Pohmen R, Schulz R, Hudson H, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-752.
12. Rees D, Palmer R, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Nat Acad Sci 1989; 86:3375-3378.
13. Harper A, Blythe WR, Carlton J, et al. Nitric oxide in the rat vestibular system. Otolaryngol Head Neck Surg 1994; 111:430-438.
14. Polloch JS, Försterman U, Mitchell JA, et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci 1991, 88:10480-10484.
15. 2+ dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res 1989; 164:678-685
16. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 1992; 13:427-434.
17. Noris M, Bengmi A, Boccardo P. et al. Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44:445-450.
18. Bergström J, Alvestrand A, Furst P, et al. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990, 38:108-114.
19. Garibotto G, Deferari G, Robando C, et al. Effects of a protein meal on amino acid profile in patients with chronic renal failure. Nephron 1993; 64:216-225.
20. Ladislaw S, Berg R, Kopple J, et al. Pattern of fasting plasma amino acid levels in chronic renal insufficiency. Results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1994; 23:504-513.
21. Bucala R, Tracey K, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 1991; 87:432-438.
22. Tesch JW, Regh WR, Sievers RE. Microdetermination of nitrates and nitrites in saliva, blood, water and suspended particles in air by gas chromatography. J Chromatography 1976; 126:743-755.
23. Darrel H, Spackman H, Stein WH, et al. Automatic recording apparatus for use in the chromatography of amino acids. Analyt Chem 1958; 30:1190-1206.
24. Backman V, Pettersson A. Determination of dimethylated arginines in human plasma by high performance liquid chromatography. J Chromatography (referred for publication) 1997.
25. Jakob G, Mair J, Puschendorf B. Direct determination of cyclic guanosine monophosphate in plasma. Clin Chem 1993; 39:2530-2531.
26. Bergström J, Wehle B. No change in corrected B2-microglobulin concentration after cuprophane hemodialysis. Lancet 1987; 14:628-629.
27. MacAllister R, Rambausek M, Vallance P, Williams D, Huffman KH, Ritz E. Concentration of dimethyl L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 1996; 11:2449-2452.
28. Anderstam B, Katzarski K, Bergström J. Methylarginines in uremia. JASN 1994; 5:572 (abstr).
29. Vinay P, Madure F, Prudhomme L, Austin JS, Blaise G, Prudhomme M. Nitric oxide in expiratory air in dialyzed patients. JASN 1995; 6:590 (abstr).
30. Wilcox C, Deng X, Doll A, Snellen H, Welch W. Nitric oxide mediates renal vasodilation during erythropoietin-induced polycythemia. Kidney Int 1993; 44:430-435.
31. Beasley D, Brenner BM. Role of nitric oxide in hemodialysis hypotension. Kidney Int 1992; 42:96-100.
32. Henderson LW, Koch KM, Dinarello CA, et al. Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1983; 1:3-8.
33. Yokokawa K, Mankus R, Saklayen M, Masakazu K, Yasuwari K, Minami M, et al. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Int Med 1995; 123:35-37.
34. Arese M, Bussolino F, Navino C, et al. Removal of constitutive and inducible nitric oxide-blocking compounds during hemodialysis. JASN 1993; 4:331 (abstr).
35. Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
36. Sanders BW. Role of nitric oxide in regulation of blood pressure. J Nephrol 1992; 5:23-30.